HIMS Hims: Net earnings per share for the last 12 months

HIMS (Hers) - company brandmark

Hims & Hers Health (HIMS) is expanding its digital clinic by leveraging demand for affordable GLP-1 and AI-driven therapy. The historical YoY TTM EPS delta within a sideways range aligns revenue with expenses, where the value of -238.20 serves as the baseline metric. A recurring payment model for medications ensures a steady cash flow, while a strong brand and personalized programs solidify market positioning and protect margins.

HIMS forhims.com: Net earnings per share for the last 12 months in the range 02/11/2024 - 11/17/2026

Financial and market metric breakdowns for Hims & Hers Health (HIMS)

- market price and analyst price targets:
- company stock capitalization data:
Fundamental company valuation:Hims & Hers HIMS
Manufactured products of Hers

Under the leadership of Andrew Dudum, Hims & Hers Health (HIMS) is scaling its subscription model through personalized products. The relative EPS YoY TTM growth trend reflects the change in net income per share over the last twelve months compared to the previous year. This metric measures the efficiency of converting revenue into actual shareholder income, excluding one-time factors. The rising line on this chart confirms the fundamental strengthening of the business's capitalization.